CABINET MEDICAL DU DOCTEUR DRAMAIX
0556.995.378 · rovalta.com · 28/09/2026
NORMAL SITUATION
CABINET MEDICAL DU DOCTEUR DRAMAIX
Company — Normal situation.
Financial year 2023 · Closed on 30/09/2023
Net result28,1 k €+15,2 %over 1 year
Gross margin42,9 k €+5,6 %over 1 year
Equity149,2 k €+23,2 %over 1 year
Overview
Identity
Source · BCE/KBOCABINET MEDICAL DU DOCTEUR DRAMAIX is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0556.995.378
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 42,9 k € | +5.6% | 40,6 k € | +793% | 4,6 k € | -93.0% | 65,3 k € | +3.6% | 63,1 k € |
| EBITDA | 42,9 k € | +5.6% | 40,6 k € | +793% | 4,6 k € | -93.0% | 65,1 k € | +3.6% | 62,9 k € |
| Operating result | 36,7 k € | +5.9% | 34,7 k € | +2390% | -1,5 k € | -103% | 58 k € | +3.2% | 56,2 k € |
| Net result | 28,1 k € | +15.2% | 24,4 k € | +11146% | 216,7 € | -99.6% | 51 k € | +6.3% | 48 k € |
| Balance sheet | |||||||||
| Equity | 149,2 k € | +23.2% | 121,1 k € | +25.2% | 96,8 k € | +0.2% | 96,5 k € | 0.0% | 96,5 k € |
| Total assets | 161,4 k € | +21.3% | 133,1 k € | +27.8% | 104,1 k € | -50.0% | 208,1 k € | +64.6% | 126,4 k € |
| Cash | 14,2 k € | -52.3% | 29,8 k € | +72.0% | 17,3 k € | -0.5% | 17,4 k € | -39.4% | 28,7 k € |
| Debts | 12,1 k € | +1.5% | 11,9 k € | +62.0% | 7,4 k € | -93.4% | 111,6 k € | +273% | 29,9 k € |
Board of directors
Source · NBB, accounts to 30/09/20231 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Pierre DRAMAIX | DirectorMandateended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marie-Charlotte DRAMAIX | MandateDirectoruntil 31/07/2020 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 | 01/10/2017 |
| Closing of the financial year | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 | 30/09/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/04/2024 | 25/04/2023 | 31/03/2022 | 29/04/2021 | 29/05/2020 | 30/04/2019 |
| General meeting | 22/04/2024 | 27/02/2023 | 07/03/2022 | 01/03/2021 | 02/03/2020 | 04/03/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2023 | 22/04/2024 | 29/04/2024 | French | |
| Micro model | 30/09/2022 | 27/02/2023 | 25/04/2023 | French | |
| Micro model | 30/09/2021 | 07/03/2022 | 31/03/2022 | French | |
| Micro model | 30/09/2020 | 01/03/2021 | 29/04/2021 | French | |
| Micro model | 30/09/2019 | 02/03/2020 | 29/05/2020 | French | |
| Micro model | 30/09/2018 | 04/03/2019 | 30/04/2019 | French | |
| Micro model | 30/09/2017 | 05/03/2018 | 24/04/2018 | French | |
| Abridged model | 30/09/2016 | 06/03/2017 | 09/05/2017 | French | |
| Abridged model | 30/09/2015 | 07/03/2016 | 29/04/2016 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20231 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean-Pierre DRAMAIX | DirectorMandateended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marie-Charlotte DRAMAIX | MandateDirectoruntil 31/07/2020 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings9 filings
Mandates
Marie-Charlotte DRAMAIX
201520162017201820192020202120222023202420252026
CABINET MEDICAL DU DOCTEUR DRAMAIX
Rue du Trieu-Maquette(S) 58, 7332 Sirault
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue du Trieu-Maquette(S) 58, 7332 Sirault | accounts 2022 → 2023 | Accounts 2023 · 2024-00081306 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CABINET MEDICAL DU DOCTEUR DRAMAIX | accounts 2022 → 2023 | Accounts 2023 · 2024-00081306 |
Events
- 2023Annual accounts 202328,1 k €↑
- 2022Annual accounts 202224,4 k €↑
- 2021Annual accounts 2021216,7 €↓
- 2020Annual accounts 202051 k €↑
- 2019Annual accounts 201948 k €↑
- 2018Annual accounts 201830,7 k €↑
- 2017Annual accounts 201722,9 k €↓
- 2016Annual accounts 201635,4 k €↑
- 2015Annual accounts 201519,7 k €